Search research articles
Contact Us
Filters
Showing results (81-90 of 105) with videos related to
Page
of 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 7, 2006
Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study
Alba A Brandes, Alicia Tosoni, Giovanna Cavallo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2008
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients
Alba A Brandes, Enrico Franceschi, Alicia Tosoni, et al.
Anticancer Research
|
March 10, 2015
The effect of re-operation on survival in patients with recurrent glioblastoma
Enrico Franceschi, Marco Bartolotti, Alicia Tosoni, et al.
Expert Review of Anticancer Therapy
|
July 14, 2025
Emerging strategies and advances in the management of sinonasal carcinoma
Alicia Tosoni, Maria Pia Foschini, Ernesto Pasquini, et al.
Future Oncology (London, England)
|
May 10, 2018
Temozolomide rechallenge in recurrent glioblastoma: when is it useful?
Enrico Franceschi, Giuseppe Lamberti, Michela Visani, et al.
Oncotarget
|
September 15, 2017
Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study
Alba A Brandes, Gaetano Finocchiaro, Vittorina Zagonel, et al.
Pathology, Research and Practice
|
August 20, 2024
TP53 mutations and survival in patients with histologically defined Glioblastoma, IDH-wildtype
Vincenzo Di Nunno, Lidia Gatto, Alicia Tosoni, et al.
Journal of Neuro-Oncology
|
June 27, 2022
Machine learning in neuro-oncology: toward novel development fields
Vincenzo Di Nunno, Mario Fordellone, Giuseppe Minniti, et al.
Oral Oncology
|
August 10, 2025
The role of systemic therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma progressed to immunotherapy: A systematic review and meta analysis
Alicia Tosoni, Vincenzo Di Nunno, Andrea Carlini, et al.
Journal of Neuro-Oncology
|
November 5, 2014
Post progression survival in glioblastoma: where are we?
Enrico Franceschi, Mario Ermani, Stefania Bartolini, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 105) with videos related to
Sort By:
Page
of 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 7, 2006
Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study
Alba A Brandes, Alicia Tosoni, Giovanna Cavallo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2008
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients
Alba A Brandes, Enrico Franceschi, Alicia Tosoni, et al.
Anticancer Research
|
March 10, 2015
The effect of re-operation on survival in patients with recurrent glioblastoma
Enrico Franceschi, Marco Bartolotti, Alicia Tosoni, et al.
Expert Review of Anticancer Therapy
|
July 14, 2025
Emerging strategies and advances in the management of sinonasal carcinoma
Alicia Tosoni, Maria Pia Foschini, Ernesto Pasquini, et al.
Future Oncology (London, England)
|
May 10, 2018
Temozolomide rechallenge in recurrent glioblastoma: when is it useful?
Enrico Franceschi, Giuseppe Lamberti, Michela Visani, et al.
Oncotarget
|
September 15, 2017
Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study
Alba A Brandes, Gaetano Finocchiaro, Vittorina Zagonel, et al.
Pathology, Research and Practice
|
August 20, 2024
TP53 mutations and survival in patients with histologically defined Glioblastoma, IDH-wildtype
Vincenzo Di Nunno, Lidia Gatto, Alicia Tosoni, et al.
Journal of Neuro-Oncology
|
June 27, 2022
Machine learning in neuro-oncology: toward novel development fields
Vincenzo Di Nunno, Mario Fordellone, Giuseppe Minniti, et al.
Oral Oncology
|
August 10, 2025
The role of systemic therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma progressed to immunotherapy: A systematic review and meta analysis
Alicia Tosoni, Vincenzo Di Nunno, Andrea Carlini, et al.
Journal of Neuro-Oncology
|
November 5, 2014
Post progression survival in glioblastoma: where are we?
Enrico Franceschi, Mario Ermani, Stefania Bartolini, et al.
Page
of 11